News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

Epigenomics AG Plans to Challenge NCD Decision and Unveils Its Next Generation Liquid Biopsy Test for Colorectal Cancer Screening

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous/Scientific publication21.01.2021 / 10:02 The issuer is solely responsible for the content of this announcement. Epigenomics AG Plans to Challenge NCD Decision and Unveils Its Next Generation Liquid Biopsy Test for Colorectal Cancer Screening Company evaluating all options to challenge CMS’ decision to non-cover the Epi proColon test New […]

Read more

Epigenomics AG reports financial results for the first nine months of 2020

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/9 Month figures12.11.2020 / 08:47 The issuer is solely responsible for the content of this announcement. Epigenomics AG reports financial results for the first nine months of 2020 Berlin (Germany) and San Diego, CA (U.S.A.), November 12, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, the […]

Read more

Epigenomics AG: Notice of Loss pursuant to § 92 par. 1 AktG

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous/AGM/EGM26.10.2020 / 10:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG: Notice of Loss pursuant to § 92 par. 1 AktG Berlin, October 26, 2020 – The Executive Board of Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) notifies that according to […]

Read more

Epigenomics AG hosts conference call on preliminary CMS reimbursement decision

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous19.10.2020 / 08:30 The issuer is solely responsible for the content of this announcement. Epigenomics AG hosts conference call on preliminary CMS reimbursement decision Berlin (Germany) and San Diego, CA (USA), October 19, 2020 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) is appalled and vehemently […]

Read more

Epigenomics AG: CMS Still Actively Working on Proposed Decision Memo with Goal to Publish As Soon As Possible

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous31.08.2020 / 07:34 The issuer is solely responsible for the content of this announcement. CMS Still Actively Working on Proposed Decision Memo with Goal to Publish As Soon As Possible Berlin (Germany) and San Diego, CA (USA), August 31, 2020 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; […]

Read more

Epigenomics AG presents operational highlights and reports financial results for first six months of 2020

DGAP-News: Epigenomics AG / Key word(s): Half Year Results/Quarter Results13.08.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG presents operational highlights and reports financial results for first six months of 2020 Berlin (Germany) and San Diego, CA (U.S.A.), August 13, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, […]

Read more